Central Nervous System Therapeutics Market Research Report by Diseases, Drug Class, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Central Nervous System Therapeutics Market Research Report by Diseases, Drug Class, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Central Nervous System Therapeutics Market size was estimated at USD 59.32 billion in 2021 and expected to reach USD 64.48 billion in 2022, and is projected to grow at a CAGR 8.95% to reach USD 99.24 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Central Nervous System Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Diseases, the market was studied across Cancer, Degenerative Diseases, Infectious Diseases, Mental Health, Neurovascular Diseases, and Trauma. The Degenerative Diseases is further studied across Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Parkinson's Disease. The Mental Health is further studied across Anxiety Disorders, Epilepsy, and Psychotic Disorders.

Based on Drug Class, the market was studied across Analgesics, Anesthetics, Anti-Epileptics, Anti-Parkinson Drugs, Antidepressant, and CNS stimulants.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Central Nervous System Therapeutics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Central Nervous System Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Central Nervous System Therapeutics Market, including AbbVie Inc., AC Immune SA, Alector, Inc., Alkermes PLC, AstraZeneca PLC, Bristol-Myers Squibb Company, Cipla Inc., Eisai Co. Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC., H. Lundbeck A/S, Lupin Limited, Merck KGaA, Otsuka Pharmaceutical Co. Ltd, Pfizer Inc., Sanofi, Takeda Pharmaceutical Company Limited, TauRx Pharmaceuticals Ltd, vTv Therapeutics Inc., and Wren Therapeutics Limited.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Central Nervous System Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Central Nervous System Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Central Nervous System Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Central Nervous System Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Central Nervous System Therapeutics Market?
6. What is the market share of the leading vendors in the Global Central Nervous System Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Central Nervous System Therapeutics Market?

Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of CNS disorders and increasing demand for effective therapeutic options
5.1.1.2. Increasing approval of generic products due to patent expiration of key products
5.1.1.3. Improving healthcare infrastructure in emerging markets
5.1.2. Restraints
5.1.2.1. Concerns associated with increasing prices of new treatments
5.1.3. Opportunities
5.1.3.1. Advancements in diagnostics and therapeutics of CNS diseases
5.1.3.2. Constant R&D efforts by pharmaceutical companies globally
5.1.4. Challenges
5.1.4.1. Strict & extended drug approval procedures
5.2. Cumulative Impact of COVID-19
6. Central Nervous System Therapeutics Market, by Diseases
6.1. Introduction
6.2. Cancer
6.3. Degenerative Diseases
6.4.1. Alzheimer's Disease
6.4.2. Amyotrophic Lateral Sclerosis
6.4.3. Multiple Sclerosis
6.4.4. Parkinson's Disease
6.4. Infectious Diseases
6.5. Mental Health
6.6.1. Anxiety Disorders
6.6.2. Epilepsy
6.6.3. Psychotic Disorders
6.6. Neurovascular Diseases
6.7. Trauma
7. Central Nervous System Therapeutics Market, by Drug Class
7.1. Introduction
7.2. Analgesics
7.3. Anesthetics
7.4. Anti-Epileptics
7.5. Anti-Parkinson Drugs
7.6. Antidepressant
7.7. CNS stimulants
8. Americas Central Nervous System Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Central Nervous System Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Central Nervous System Therapeutics Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AbbVie Inc.
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. AC Immune SA
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Alector, Inc.
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Alkermes PLC
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. AstraZeneca PLC
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Bristol-Myers Squibb Company
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Cipla Inc.
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Eisai Co. Ltd.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Eli Lilly and Company
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. F. Hoffmann-La Roche Ltd
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. GlaxoSmithKline PLC.
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. H. Lundbeck A/S
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Lupin Limited
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Merck KGaA
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Otsuka Pharmaceutical Co. Ltd
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Pfizer Inc.
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Sanofi
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Takeda Pharmaceutical Company Limited
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. TauRx Pharmaceuticals Ltd
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. vTv Therapeutics Inc.
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Wren Therapeutics Limited
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET DYNAMICS
FIGURE 11. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2021 VS 2027 (%)
FIGURE 12. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY DISEASES, 2027
FIGURE 14. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DEGENERATIVE DISEASES, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANXIETY DISORDERS, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY EPILEPSY, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY PSYCHOTIC DISORDERS, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY NEUROVASCULAR DISEASES, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY TRAUMA, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (%)
FIGURE 28. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUG CLASS, 2027
FIGURE 30. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANESTHETICS, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTICS, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTI-PARKINSON DRUGS, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANT, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY CNS STIMULANTS, 2018-2027 (USD MILLION)
FIGURE 36. AMERICAS CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. AMERICAS CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 38. AMERICAS CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 39. AMERICAS CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 40. ARGENTINA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. BRAZIL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. CANADA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. MEXICO CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. UNITED STATES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. UNITED STATES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 46. UNITED STATES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 47. UNITED STATES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 48. ASIA-PACIFIC CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. ASIA-PACIFIC CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 50. ASIA-PACIFIC CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 51. ASIA-PACIFIC CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 52. AUSTRALIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. CHINA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. INDIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. INDONESIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. JAPAN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. MALAYSIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. PHILIPPINES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. SINGAPORE CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. SOUTH KOREA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. TAIWAN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. THAILAND CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. VIETNAM CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 68. DENMARK CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. EGYPT CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. FINLAND CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. FRANCE CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. GERMANY CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. ISRAEL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. ITALY CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. NETHERLANDS CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. NIGERIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. NORWAY CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. POLAND CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. QATAR CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. RUSSIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SAUDI ARABIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. SOUTH AFRICA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. SPAIN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. SWEDEN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. SWITZERLAND CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. TURKEY CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. UNITED ARAB EMIRATES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. UNITED KINGDOM CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 90. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 91. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2021
TABLE 3. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DEGENERATIVE DISEASES, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DEGENERATIVE DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DEGENERATIVE DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANXIETY DISORDERS, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANXIETY DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANXIETY DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY EPILEPSY, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY PSYCHOTIC DISORDERS, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY PSYCHOTIC DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY PSYCHOTIC DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY NEUROVASCULAR DISEASES, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY NEUROVASCULAR DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY NEUROVASCULAR DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY TRAUMA, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANESTHETICS, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANESTHETICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANESTHETICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTICS, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 56. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTI-PARKINSON DRUGS, 2018-2027 (USD MILLION)
TABLE 57. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTI-PARKINSON DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 58. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTI-PARKINSON DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 59. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANT, 2018-2027 (USD MILLION)
TABLE 60. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANT, BY REGION, 2018-2027 (USD MILLION)
TABLE 61. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANT, BY REGION, 2018-2027 (USD MILLION)
TABLE 62. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY CNS STIMULANTS, 2018-2027 (USD MILLION)
TABLE 63. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY CNS STIMULANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 64. GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY CNS STIMULANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 65. AMERICAS CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 66. AMERICAS CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 67. AMERICAS CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 68. AMERICAS CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 69. ARGENTINA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 70. ARGENTINA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 71. ARGENTINA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 72. BRAZIL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 73. BRAZIL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 74. BRAZIL CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 75. CANADA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 76. CANADA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 77. CANADA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 78. MEXICO CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 79. MEXICO CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 80. MEXICO CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 81. UNITED STATES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 82. UNITED STATES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 83. UNITED STATES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 84. UNITED STATES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 85. ASIA-PACIFIC CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 87. ASIA-PACIFIC CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 88. ASIA-PACIFIC CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 89. AUSTRALIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 90. AUSTRALIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 91. AUSTRALIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 92. CHINA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 93. CHINA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 94. CHINA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 95. INDIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 96. INDIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 97. INDIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 98. INDONESIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 99. INDONESIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 100. INDONESIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 101. JAPAN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 102. JAPAN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 103. JAPAN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 104. MALAYSIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 105. MALAYSIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 106. MALAYSIA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 107. PHILIPPINES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 108. PHILIPPINES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 109. PHILIPPINES CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 110. SINGAPORE CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 111. SINGAPORE CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 112. SINGAPORE CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 113. SOUTH KOREA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 114. SOUTH KOREA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 115. SOUTH KOREA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 116. TAIWAN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 117. TAIWAN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 118. TAIWAN CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 119. THAILAND CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 120. THAILAND CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 121. THAILAND CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 122. VIETNAM CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 123. VIETNAM CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 124. VIETNAM CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 129. DENMARK CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. DENMARK CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 131. DENMARK CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 132. EGYPT CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. EGYPT CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
TABLE 134. EGYPT CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 135. FINLAND CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 136. FINLAND CENTRAL NERVOUS SYSTEM THERAPEUTICS MARKET SIZE, BY DISEASES, 2018-2027 (USD MILLION)
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings